Table: Enbio Holdings - 6-MTH group results
Nov 12 (Reuters)-
Enbio Holdings, Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.30 3.62 8.55
(+18.8 pct) (-15.5 pct) (+25.0 pct)
Operating 702 mln 410 mln 749 mln
(+71.2 pct) (-34.5 pct) (+21.3 pct)
Recurring 674 mln 382 mln 645 mln
(+76.1 pct) (-26.2 pct) (+8.9 pct)
Net 375 mln 263 mln 361 mln
(+42.3 pct) (-49.6 pct) (+18.8 pct)
EPS 56.62 yen 40.15 yen 54.44 yen
EPS Diluted 56.58 yen 39.73 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Enbio Holdings, Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6092.T